NASDAQ:JSPR Completes Kira Pharmaceuticals Acquisition in Stock-Only Deal
Jasper Therapeutics has finalized its acquisition of Kira Pharmaceuticals in a $132 million all-stock transaction. This consolidation integrates Kira’s complement-targeted pipeline with Jasper’s hematopoietic stem cell conditioning platform, aiming to ... Read More